4502.T PE Benchmarks

Takeda Pharmaceutical Company Limited • Healthcare

PE Type:

Period:

Data Quality:Good

Current PE Ratio

47.3

Diluted • annual

Forward PE

24.0

NTM Estimate

Sector Companies

500

310 with PE data

Sector Median PE

75.4

310 companies

Peer Companies

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

310

Median PE

75.4

PE Range

0.8 - 198.6

Forward PE Median

21.2

Healthcare Sector

2914 companies • sector

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:22.2

Average PE:35.1

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.7 - 43.4

Min: 0.1Max: 198.8

Current: 47.3

Drug Manufacturers - Specialty & Generic Industry

704 companies • industry

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:20.8

Average PE:34.4

Min PE:0.1

Max PE:196.9

25th-75th %ile:11.3 - 42.1

Min: 0.1Max: 196.9

Current: 47.3

Peer Companies

5 companies • peers

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:14.8

Average PE:15.0

Min PE:12.3

Max PE:19.8

25th-75th %ile:12.3 - 15.5

Min: 12.3Max: 19.8

Current: 47.3

JP Market

4338 companies • country

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:13.5

Average PE:19.8

Min PE:0.1

Max PE:196.8

25th-75th %ile:8.8 - 21.8

Min: 0.1Max: 196.8

Current: 47.3

Peer Companies

(5 companies)

8306.T

8316.T

4503.T

4568.T

9433.T

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 6/17/2026, 9:06:30 AM• Based on latest annual diluted PE ratios

4502.T PE Benchmarks

Takeda Pharmaceutical Company Limited • Healthcare

PE Type:

Period:

Data Quality:Good

Current PE Ratio

47.3

Diluted • annual

Forward PE

24.0

NTM Estimate

Sector Companies

500

310 with PE data

Sector Median PE

75.4

310 companies

Peer Companies

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

310

Median PE

75.4

PE Range

0.8 - 198.6

Forward PE Median

21.2

Healthcare Sector

2914 companies • sector

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:22.2

Average PE:35.1

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.7 - 43.4

Min: 0.1Max: 198.8

Current: 47.3

Drug Manufacturers - Specialty & Generic Industry

704 companies • industry

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:20.8

Average PE:34.4

Min PE:0.1

Max PE:196.9

25th-75th %ile:11.3 - 42.1

Min: 0.1Max: 196.9

Current: 47.3

Peer Companies

5 companies • peers

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:14.8

Average PE:15.0

Min PE:12.3

Max PE:19.8

25th-75th %ile:12.3 - 15.5

Min: 12.3Max: 19.8

Current: 47.3

JP Market

4338 companies • country

High PE(75th %ile)

Current PE:47.3

Forward PE:24.0

Median PE:13.5

Average PE:19.8

Min PE:0.1

Max PE:196.8

25th-75th %ile:8.8 - 21.8

Min: 0.1Max: 196.8

Current: 47.3

Peer Companies

(5 companies)

8306.T

8316.T

4503.T

4568.T

9433.T

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 6/17/2026, 9:06:30 AM• Based on latest annual diluted PE ratios